Pilot among the first in large, integrated clinical cancer setting;
provides more holistic approach to cancer treatment that focuses
on quality, patient preferences

MD Anderson News Release 12/16/2014

The University of Texas MD Anderson Cancer Center and
UnitedHealthcare have launched a pilot to explore a new cancer care
payment model for head and neck cancers that focuses on quality
patient care and outcomes...

Publications

Clinical Trials

MD Anderson

The Food and Drug Administration’s (FDA) approval of a new vaccine
that targets five additional strains of human papilloma virus (HPV)
fortifies a proven cancer-prevention weapon, according to Ronald A.
DePinho, M.D., president of The University of Texas MD Anderson Cancer
Center.

The FDA greenlighted use of Gardasil 9 for the
prevention of certain cancers caused by nine HPV...